子宫腺肌病损害生育力与围产结局:新型小鼠模型及着床期子宫基因谱改变的启示
研究通过机械破坏子宫内膜-肌层界面建立Bagg Albino/c小鼠子宫腺肌病模型,随机分为腺肌病组与假手术对照组,评估着床部位分布、着床率、妊娠丢失、胎儿生长及产后子宫恢复,并对交配后4.5天着床部位与着床间区域子宫组织行RNA测序。腺肌病组着床部位分布不规则、胚胎间距缩短,妊娠中期妊娠丢失明显增加、存活胚胎体积减小,子宫肌层结构广泛破坏伴局部炎症反应增强,免疫调节、凋亡调控及代谢相关基因失调,磷脂酰肌醇3-激酶-Akt、丝裂原活化蛋白激酶及肿瘤坏死因子信号通路显著富集。
要点
- 腺肌病组小鼠着床部位分布不规则且胚胎间距缩短,着床空间组织受损。
- 早期妊娠胚胎总数两组无显著差异,但妊娠中期妊娠丢失明显增加、存活胚胎体积减小。
- 腺肌病子宫肌层结构广泛破坏、局部炎症反应增强,PI3K-Akt、MAPK及TNF通路显著富集。
核心结论
- 腺肌病通过破坏子宫环境并干扰胚胎着床与发育所需的關鍵分子通路,对生育力及围产结局产生不良影响。
- 研究结果为腺肌病病理生理学提供认识,并指出磷脂酰肌醇3-激酶-Akt通路、丝裂原活化蛋白激酶及肿瘤坏死因子通路等潜在分子靶点。
研究设计与样本
- 在雌性Bagg Albino/c小鼠中通过破坏子宫内膜-肌层界面建立机械诱导的子宫腺肌病模型,以模拟人类临床状况。
- 小鼠随机分为腺肌病组与假手术对照组,在多个妊娠时间点系统评估生殖结局。
- 对交配后4.5天着床部位与着床间区域子宫组织行RNA测序,并作差异基因表达分析及Gene Ontology与Kyoto Encyclopedia of Genes and Genomes富集分析。
主要发现
- 腺肌病组着床部位分布不规则、胚胎间距缩短,发育中胚胎的空间组织受损。
- 早期妊娠胚胎总数两组无显著差异,但妊娠中期妊娠丢失明显增加,存活胚胎体积减小。
- 组织学评估显示腺肌病子宫肌层结构广泛破坏、局部炎症反应增强。
- RNA测序显示免疫调节、凋亡调控及代谢过程相关多个基因失调,磷脂酰肌醇3-激酶-Akt通路、丝裂原活化蛋白激酶及肿瘤坏死因子信号通路显著富集。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adenomyosis is a uterine disorder closely linked to infertility and adverse pregnancy outcomes. Despite its clinical significance, the mechanisms by which adenomyosis impairs embryo implantation and perinatal outcomes remain incompletely defined. Previous studies have indicated that alterations in the uterine microenvironment may contribute to these reproductive challenges. OBJECTIVE: To investigate the effects of adenomyosis on fertility and perinatal outcomes using a novel murine model and to identify molecular pathways involved in implantation failure and pregnancy loss. STUDY DESIGN: A mechanically induced adenomyosis model was established in female Bagg Albino/c mice through endometrial-myometrial interface disruption to closely simulate the clinical condition observed in humans. Mice were randomly assigned to either the adenomyosis group or a sham-operated control group. Reproductive outcomes were systematically assessed at multiple gestational time points, focusing on embryo implantation site distribution, implantation rates, pregnancy loss, fetal growth parameters, and postnatal uterine recovery. In parallel, uterine tissues collected from implantation sites and interimplantation regions at 4.5 days postcoitus were subjected to RNA sequencing. Differential gene expression analyses were performed, and enriched pathways were identified using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment tools. RESULTS: Mice in the adenomyosis group demonstrated significant disruptions in the uterine microenvironment compared to controls. Notably, the adenomyosis group exhibited irregular distribution of implantation sites with reduced interembryo distances, leading to compromised spatial organization of the developing conceptuses. Although the total number of embryos at early gestation did not differ significantly between groups, a marked increase in pregnancy loss was observed during mid-gestation, accompanied by a reduction in the size of surviving embryos. Histological evaluation revealed extensive architectural disruptions in the uterine muscle layers and increased local inflammatory responses in adenomyotic uteri. RNA sequencing further revealed that adenomyosis was associated with the dysregulation of multiple genes involved in immune modulation, apoptotic regulation, and metabolic processes. In particular, significant enrichment of the phosphoinositide 3-kinase-Akt pathway, mitogen-activated protein kinase, and tumor necrosis factor signaling pathways was observed, suggesting that variation in these cascades may underlie the impaired uterine receptivity and embryo development seen in adenomyosis. CONCLUSION: Our findings indicate that adenomyosis exerts a adverse effect on fertility and perinatal outcomes by disrupting the uterine environment and interfering with critical molecular pathways essential for proper embryo implantation and development. The results of this study not only enhance our understanding of adenomyosis pathophysiology but also pinpoint potential molecular targets-such as the phosphoinositide 3-kinase-Akt pathway, mitogen-activated protein kinase, and tumor necrosis factor pathways-for therapeutic intervention. These insights offer promising targets for developing treatments aimed at reversing the adverse reproductive impacts associated with adenomyosis.
引用
- Zheng H, Liu M, Su Q, et al. Impaired fertility and perinatal outcomes in adenomyosis: insights from a novel murine model and uterine gene profile alterations during implantations. Am J Obstet Gynecol. 2025. PMID: 39986340. doi:10.1016/j.ajog.2025.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。